Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework
Mar 29 2020
•
By
Derrick Gingery
So far, FDA staff have smoothly transitioned to mass-telework, the Office of New Drugs and Office of Generic Drugs directors said in an interview. • Source: File photo
More from Product Reviews
More from Pink Sheet